Cargando...
Escitalopram for Major Depression in Parkinson’s Disease: An Open-Label, Flexible-Dosage Study
Depression and antidepressant use are common in Parkinson’s disease, but the benefit of selective serotonin reuptake inhibitor (SSRI) treatment in this population has not been established. The authors treated 14 Parkinson’s disease patients with major depression with escitalopram in an open-label st...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2006
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1761053/ https://ncbi.nlm.nih.gov/pubmed/16963587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.neuropsych.18.3.377 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|